Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 48: 1901-1912, 2002;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (46)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wong, L.-J. C.
Right arrow Articles by Tan, D.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wong, L.-J. C.
Right arrow Articles by Tan, D.-J.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2002;48:1901-1912.)
© 2002 American Association for Clinical Chemistry, Inc.

Comprehensive Scanning of the Entire Mitochondrial Genome for Mutations

Lee-Jun C. Wonga1, Min-Hui Liang1, Haeyoung Kwon1, John Park1, Ren-Kui Bai1 and Duan-Jun Tan1

1 Institute for Molecular and Human Genetics, Georgetown University Medical Center, Washington, DC 20007.

aAddress correspondence to this author at: Institute for Molecular and Human Genetics, Georgetown University Medical Center, M4000, 3800 Reservoir Rd. NW, Washington, DC 20007. Fax 202-784-1770; e-mail wonglj{at}georgetown.edu.

Background: Definitive molecular diagnosis of mitochondrial disorders has been greatly hindered by the tremendous clinical and genetic heterogeneity, the heteroplasmic condition of pathogenic mutations, and the presence of numerous homoplasmic mitochondrial DNA (mtDNA) variations with unknown significance. We used temporal temperature gradient gel electrophoresis (TTGE) to detect heteroplasmic mutations from homoplasmic variations in the whole mitochondrial genome.

Methods: We screened 179 unrelated patients by TTGE with use of 32 overlapping primer pairs. Mutations were identified by direct sequencing of the PCR products and confirmed by PCR with allele-specific oligonucleotide or restriction fragment length polymorphism analysis.

Results: We detected 71 heteroplasmic and 647 homoplasmic banding patterns. Sequencing of the heteroplasmic fragments identified 68 distinct novel mutations and 132 reported sequence variations and mutations; most of them occurred only once. The deleterious nature of some of the novel mutations was established by analyzing the asymptomatic family members and the biochemical and molecular characteristics of the mutation. When the number of mutations was normalized to the size of the region, the occurrence of mutations was 2.4 times more frequent in the tRNA genes than in the mRNA (protein coding) regions.

Conclusions: Screening by TTGE detects low proportions of mutant mtDNA and distinguishes heteroplasmic from homoplasmic variations. Results from comprehensive molecular analysis should be followed up with clinical correlation to establish a guideline for complete mutational analysis of the entire mitochondrial genome and to facilitate the diagnosis of mitochondrial disorders.




The following articles in journals at HighWire Press have cited this article:


Home page
 J. Med. Genet.Home page
S M Ware, N El-Hassan, S G Kahler, Q Zhang, Y-W, E Miller, B Wong, R L Spicer, W J Craigen, B A Kozel, et al.
Infantile cardiomyopathy caused by a mutation in the overlapping region of mitochondrial ATPase 6 and 8 genes
J. Med. Genet., May 1, 2009; 46(5): 308 - 314.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
Y-G Yao, Q-P Kong, A Salas, and H-J Bandelt
Pseudomitochondrial genome haunts disease studies
J. Med. Genet., December 1, 2008; 45(12): 769 - 772.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
D. Tan, D. S. Goerlitz, R. G. Dumitrescu, D. Han, F. Seillier-Moiseiwitsch, S. M. Spernak, R. A. Orden, J. Chen, R. Goldman, and P. G. Shields
Associations between cigarette smoking and mitochondrial DNA abnormalities in buccal cells
Carcinogenesis, June 1, 2008; 29(6): 1170 - 1177.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
F.-G. Debray, M. Lambert, I. Chevalier, Y. Robitaille, J.-C. Decarie, E. A. Shoubridge, B. H. Robinson, and G. A. Mitchell
Long-term Outcome and Clinical Spectrum of 73 Pediatric Patients With Mitochondrial Diseases
Pediatrics, April 1, 2007; 119(4): 722 - 733.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
L-J C Wong, D Yim, R-K Bai, H Kwon, M M Vacek, J Zane, C L Hoppel, and D S Kerr
A novel mutation in the mitochondrial tRNASer(AGY) gene associated with mitochondrial myopathy, encephalopathy, and complex I deficiency.
J. Med. Genet., September 1, 2006; 43(9): e46 - e46.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
R.-K. Bai and L.-J. C. Wong
Simultaneous Detection and Quantification of Mitochondrial DNA Deletion(s), Depletion, and Over-Replication in Patients with Mitochondrial Disease
J. Mol. Diagn., November 1, 2005; 7(5): 613 - 622.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
J. P. Jakupciak, W. Wang, M. E. Markowitz, D. Ally, M. Coble, S. Srivastava, A. Maitra, P. E. Barker, D. Sidransky, and C. D. O'Connell
Mitochondrial DNA as a Cancer Biomarker
J. Mol. Diagn., May 1, 2005; 7(2): 258 - 267.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
I. Schrijver, S. Ramalingam, R. Sankaran, S. Swanson, C. L.M. Dunlop, S. Keiles, R. B. Moss, J. Oehlert, P. Gardner, E. R. Wassman, et al.
Diagnostic Testing by CFTR Gene Mutation Analysis in a Large Group of Hispanics: Novel Mutations and Assessment of a Population-Specific Mutation Spectrum
J. Mol. Diagn., May 1, 2005; 7(2): 289 - 299.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
W. Girald-Rosa, R. A. Vleugels, A. C. Musiek, and J. E. Sligh
High-Throughput Mitochondrial Genome Screening Method for Nonmelanoma Skin Cancer Using Multiplexed Temperature Gradient Capillary Electrophoresis
Clin. Chem., February 1, 2005; 51(2): 305 - 311.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
F. Scaglia, J. A. Towbin, W. J. Craigen, J. W. Belmont, E. O. Smith, S. R. Neish, S. M. Ware, J. V. Hunter, S. D. Fernbach, G. D. Vladutiu, et al.
Clinical Spectrum, Morbidity, and Mortality in 113 Pediatric Patients With Mitochondrial Disease
Pediatrics, October 1, 2004; 114(4): 925 - 931.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
A. Kurtz, M. Lueth, L. Kluwe, T. Zhang, R. Foster, V.-F. Mautner, M. Hartmann, D.-J. Tan, R. L. Martuza, R. E. Friedrich, et al.
Somatic Mitochondrial DNA Mutations in Neurofibromatosis Type 1-Associated Tumors
Mol. Cancer Res., August 1, 2004; 2(8): 433 - 441.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
L-J C Wong, D-J Tan, R-K Bai, K-T Yeh, and J Chang
Molecular alterations in mitochondrial DNA of hepatocellular carcinomas: is there a correlation with clinicopathological profile?
J. Med. Genet., May 1, 2004; 41(5): e65 - e65.
[Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
C. T. Moraes, D. P. Atencio, J. Oca-Cossio, and F. Diaz
Techniques and Pitfalls in the Detection of Pathogenic Mitochondrial DNA Mutations
J. Mol. Diagn., November 1, 2003; 5(4): 197 - 208.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L.-J. C. Wong, M. Lueth, X.-N. Li, C. C. Lau, and H. Vogel
Detection of Mitochondrial DNA Mutations in the Tumor and Cerebrospinal Fluid of Medulloblastoma Patients
Cancer Res., July 15, 2003; 63(14): 3866 - 3871.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Association for Clinical Chemistry.